Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Obstetrics

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44347   clinical trials with a EudraCT protocol, of which   7375   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    61 result(s) found for: Obstetrics. Displaying page 1 of 4.
    1  2  3  4  Next»
    EudraCT Number: 2016-000410-30 Sponsor Protocol Number: EstrogenPOP2 Start Date*: 2016-12-01
    Sponsor Name:Medical University of Vienna, Department of Obstetrics and Gynecology
    Full Title: PREOPERATIVE LOCALLY APPLIED OESTROGEN IN POSTMENOPAUSAL WOMEN WITH PELVIC ORGAN PROLAPSE: CHANGES IN SUBJECTIVE AND OBJECTIVE OUTCOME: A PROSPECTIVE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED ST...
    Medical condition: Pelvic organ prolapse
    Disease:
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: AT (Completed)
    Trial results: View results
    EudraCT Number: 2016-001191-30 Sponsor Protocol Number: IISR-2015-101127 Start Date*: 2017-04-25
    Sponsor Name:Department of Obstetrics & Gynecology, Copenhagen University Hospital, Rigshospitalet
    Full Title: Use of TachoSil® for the prevention of postoperative complications after groin dissection in vulva cancer patients
    Medical condition: Vulva cancer
    Disease: Version SOC Term Classification Code Term Level
    19.1 100000004864 10047750 Vulval neoplasms malignant HLT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2010-020824-23 Sponsor Protocol Number: P-piller101 Start Date*: 2010-09-01
    Sponsor Name:Karolinska University Hospital
    Full Title: P-piller och ekonomiskt beteende
    Medical condition: Healthy volontary young women
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: SE (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2012-005770-57 Sponsor Protocol Number: version121219 Start Date*: 2013-03-25
    Sponsor Name:department of OBstetrics, Sahlgrenska university hospital
    Full Title: Clinical effect of Atenativ treatment on uterine blood flow and the amount of Atenativ needed to maintain a normal antithrombin level during two weeks in early and severe preeclampsia
    Medical condition: Early and severe preeclampsia with low antithrombin activity.
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: SE (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2005-000494-22 Sponsor Protocol Number: 2004/120 Start Date*: 2005-07-12
    Sponsor Name:Department of Obstetrics and Gynecolog, Randers Centralsygehusy
    Full Title: Ny behandling af bartholins cyste/abscess med sølvnitrat
    Medical condition: Bartholins cyste/abscess
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: DK (Completed)
    Trial results: (No results available)
    EudraCT Number: 2007-004984-23 Sponsor Protocol Number: 191/2006 Start Date*: 2008-05-08
    Sponsor Name:Department of Obstetrics and Gynecology, Oulu University Hospital
    Full Title: Ehkäisylaastarin, ehkäisytabletin ja ehkäisyrenkaan vaikutukset hormonaalisiin, tulehduksellisiin ja aineenvaihdunnallisiin parametreihin hedelmällisessä iässä olevilla terveillä naisilla.
    Medical condition: Perusterveitä hedelmällisessä iässä olevia naisia.
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: FI (Completed)
    Trial results: View results
    EudraCT Number: 2012-001371-37 Sponsor Protocol Number: GDM-TREAT Start Date*: 2012-07-10
    Sponsor Name:Dr. med. Tina Vilsbøll
    Full Title: The impact of liraglutide on glucose tolerance and the risk of type 2 diabetes in women with previous gestational diabetes mellitus
    Medical condition: Gestational diabetes mellitus Non-alcoholic fatty liver disease
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004868 10018210 Gestational diabetes mellitus LLT
    20.1 10019805 - Hepatobiliary disorders 10029530 Non-alcoholic fatty liver PT
    Population Age: Adults Gender: Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2020-000233-41 Sponsor Protocol Number: OPTION Start Date*: 2020-08-25
    Sponsor Name:Sahlgrenska University Hospital
    Full Title: Labour induction in an outpatient setting - a multicenter randomized controlled trial. OPTION - OutPatienT InductiON
    Medical condition: Induction of labour
    Disease:
    Population Age: In utero, Under 18, Adults Gender: Male, Female
    Trial protocol: SE (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2017-000328-85 Sponsor Protocol Number: FINNHT1 Start Date*: 2017-05-18
    Sponsor Name:Helsinki University Hospital, Obstetrics and Gynecology
    Full Title: Randomized comparative trial between abrupt and tapered mode of discontinuation of longterm hormone therapy: Impact on endothelial function, recurrence of vasomotor symptoms and quality of life
    Medical condition: We will assess the effects of hormone therapy termination on endothelial function using biophysical (flow-mediated dilation, peripheral artery tonometry) and biochemical markers. We will compare th...
    Disease: Version SOC Term Classification Code Term Level
    20.0 10038604 - Reproductive system and breast disorders 10027311 Menopause flushing LLT
    20.0 10041244 - Social circumstances 10076936 Impaired quality of life PT
    20.1 10038604 - Reproductive system and breast disorders 10027301 Menopausal hot flushes LLT
    20.1 10022891 - Investigations 10060858 Cardiovascular function test PT
    20.0 10041244 - Social circumstances 10027308 Menopause PT
    16.1 10038604 - Reproductive system and breast disorders 10027309 Menopause and related conditions HLGT
    20.0 10007541 - Cardiac disorders 10007649 Cardiovascular disorder PT
    20.0 10041244 - Social circumstances 10051775 Postmenopause PT
    20.0 10047065 - Vascular disorders 10048554 Endothelial dysfunction PT
    Population Age: Adults Gender: Female
    Trial protocol: FI (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2020-002271-36 Sponsor Protocol Number: MEPIC Start Date*: 2021-03-09
    Sponsor Name:Danderyd Hospital
    Full Title: Mepivacaine for pain relief at insertion of intrauterine contraception (MEPIC) – a triple-blind randomized controlled trial.
    Medical condition: Insertion of intrauterine contraception
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: SE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2013-000801-21 Sponsor Protocol Number: 20130218 Start Date*: 2014-08-26
    Sponsor Name:Academic Medical Center
    Full Title: Stimulation of the ovaries in women with breast cancer undergoing fertility preservation: alternative versus standard stimulation protocols; the STIM-trial
    Medical condition: Ovarian stimulation in women with breast cancer prior to chemotherapy
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2010-020780-21 Sponsor Protocol Number: W2010IM Start Date*: 2011-03-28
    Sponsor Name:Department of Obstetrics and Gynaecology, Karolinska Institutet, Stockholm
    Full Title: Paracervical block (PCB) during II-trimester abortion – a randomized controlled trial
    Medical condition: Pain during second trimester induced abortion
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: SE (Completed)
    Trial results: View results
    EudraCT Number: 2006-006080-23 Sponsor Protocol Number: DPMFM PC1036 Start Date*: 2007-03-21
    Sponsor Name:Institute of Obstetrics and Gynaecology Trust
    Full Title: Vitamin D status in pregnancy and the effects of vitamin D supplementation in ethnic minority groups
    Medical condition: Low vitamin D levels in pregnant women especially in ethnic minority groups
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: GB (GB - no longer in EU/EEA)
    Trial results: (No results available)
    EudraCT Number: 2006-000194-29 Sponsor Protocol Number: OUHIVMproj-1-pco-hcg Start Date*: 2006-04-11
    Sponsor Name:Fertility Clinic, dept. of Obstetrics and gynecology, OUH.
    Full Title: In Vitro Maturation (IVM) as part of the treatment of infertility in women with polycystic ovaries (PCO). Is priming with hCG favourable? A prospective randomized study.
    Medical condition: Infertility in women with polycystic ovaries (PCO).
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: DK (Completed)
    Trial results: (No results available)
    EudraCT Number: 2020-002015-22 Sponsor Protocol Number: Strindfors2 Start Date*: 2022-08-12
    Sponsor Name:Dept. of Obstetrics and Gynecology, Sodersjukhuset
    Full Title: A pilot study and randomized placebo-controlled trial on the effect and timing of oral Tranexamic acid (TA) administered prepartum on postpartum haemorrhage after vaginal delivery
    Medical condition: Postpartum hemorrhage which is defined as bleeding during and after delivery that exceeds 500 ml. It is most commonly due to an atony of the uterus but may also have other causes such as tissue dam...
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004868 10071867 Postpartum bleeding LLT
    Population Age: Adults Gender: Female
    Trial protocol: SE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2016-000782-22 Sponsor Protocol Number: SAHA-Pilot-2016 Start Date*: 2017-01-03
    Sponsor Name:Medical University of Graz
    Full Title: A pilot study of peroral Vorinostat (Zolinza) in patients with refractory histone deacetylase-positive uterine sarcoma.
    Medical condition: Uterine sarcoma
    Disease:
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: AT (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2015-005247-14 Sponsor Protocol Number: CHUB-Equidol Start Date*: 2016-08-09
    Sponsor Name:Centre Hospitalier Universitaire Brugmann
    Full Title: Effect of levobupivacaine infiltration versus placebo on perineal postpartum pain in episiotomy of primiparous, after instrumental delivery: randomized double blind clinical trial.
    Medical condition: Episiotomy (inclusion of primiparous patients giving birth by instrumental delivery -Suzor forceps, vacuum extraction, Thierry spatulas with episiotomy).
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: BE (Completed)
    Trial results: View results
    EudraCT Number: 2008-007669-21 Sponsor Protocol Number: none Start Date*: 2009-12-15
    Sponsor Name:CHU of Liège
    Full Title: Effectiveness of prophylactic antibiotic intervention (fosfomycin trometamol) to prevent urinary tract infections due to urodynamic studies in women with urine incontinence or prolapsed: a randomi...
    Medical condition: The aim of the study is to assess the prophylactic use of antibiotics on urinary tract infection after urodynamic studies in women with incontinence or prolapse
    Disease:
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: BE (Completed)
    Trial results: View results
    EudraCT Number: 2019-004050-29 Sponsor Protocol Number: Vvax001-UMCG-02 Start Date*: 2020-03-30
    Sponsor Name:University Medical Center Groningen
    Full Title: A phase II study to determine the efficacy and safety of Vvax001, a therapeutic Semliki Forest Virus based cancer vaccine, in patients with HPV-16 induced grade 3 cervical intraepithelial neoplasia.
    Medical condition: HPV-16 induced pre malignant cervical lesions
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: NL (Completed)
    Trial results: (No results available)
    EudraCT Number: 2012-000356-33 Sponsor Protocol Number: oxy123 Start Date*: 2013-03-27
    Sponsor Name:Västra Götaland
    Full Title: Delay in labour due to ineffective uterine contractions is still a major problem in modern obstetric care. It is one of the main reasons for the increased rate of operative deliveries, particularly...
    Medical condition: Labor dystocia (LD) also referred to as prolonged labour is a commonly identified problem in modern delivery care with three described possible causes: inefficient uterine action, occiputposterior ...
    Disease: Version SOC Term Classification Code Term Level
    14.1 100000004868 10056139 Labour abnormal LLT
    Population Age: Adults Gender: Female
    Trial protocol: SE (Prematurely Ended)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  4  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sat Jul 05 00:53:37 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA